Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1995-11-8
|
pubmed:abstractText |
This study assesses the value of immunologic and ultrastructural methods in disclosing the lineage commitment of cells from acute leukemias (ALs). Two hundred and fifty-one ALs were characterized morphologically, cytochemically, and immunologically. Myeloperoxidase (MPO) positivity in > 3% of blasts was regarded as evidence of the myeloid origin of leukemic cells, cytoplasmic CD22 (cCD22) expression was taken as an indication for B-lineage acute lymphoblastic leukemia (ALL), and CD3+ (membrane or cytoplasmic) cases were classified as T-ALL. Diagnosis of minimally differentiated acute myeloid leukemia (AML-M0) was made when blast cells had undifferentiated features by light microscopy, reacted with at least one of the antibodies to myeloid-specific antigens (CD13, CD33, MPO), and lacked CD19, cCD22, and c/mCD3. Megakaryoblastic differentiation was demonstrated by the expression of CD41 and/or CD61. Following these criteria, 209 cases were classified as acute myeloid leukemia (AML) and 39 as ALL. Expression of lymphoid antigens was detected in 45% of AML cases and 30% of ALLs showed myeloid antigens. One case was regarded as a true biphenotypic leukemia because of the combined expression of MPO and CD33 for the myeloid lineage, and cCD3, CD2, and CD5 for the T-cell lineage. Two cases lacked signs of myeloid or lymphoid differentiation and were studied by electron microscopy methods. One displayed platelet peroxidase (PPO) activity and was classified as a megakaryoblastic variant, one other reacted with anti-CD33 and was considered AML-M0. We conclude that light microscopy and standard immunologic methods can accurately demonstrate the lineage orientation in greater than 99% of ALs. Integration with ultrastructural analysis can define the cell nature of virtually all cases of AL.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0886-0238
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
9
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
79-94
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:7559258-Adolescent,
pubmed-meshheading:7559258-Adult,
pubmed-meshheading:7559258-Aged,
pubmed-meshheading:7559258-Aged, 80 and over,
pubmed-meshheading:7559258-Bone Marrow,
pubmed-meshheading:7559258-Cell Differentiation,
pubmed-meshheading:7559258-Female,
pubmed-meshheading:7559258-Humans,
pubmed-meshheading:7559258-Immunohistochemistry,
pubmed-meshheading:7559258-Immunophenotyping,
pubmed-meshheading:7559258-Leukemia,
pubmed-meshheading:7559258-Male,
pubmed-meshheading:7559258-Microscopy, Electron,
pubmed-meshheading:7559258-Middle Aged
|
pubmed:year |
1995
|
pubmed:articleTitle |
Lineage identification of acute leukemias: relevance of immunologic and ultrastructural techniques.
|
pubmed:affiliation |
Department of Hematology, University of Rome Tor Vergata, S. Eugenio Hospital, Rome, Italy.
|
pubmed:publicationType |
Journal Article
|